Request Demo
Last update 16 May 2025
QLP-31907
Last update 16 May 2025
Overview
Basic Info
Drug Type Bispecific antibody |
Synonyms PSB 202, PSB-202, PSB202 + [3] |
Target |
Action modulators |
Mechanism CD20 modulators(B-lymphocyte antigen CD20 modulators), CD37 modulators(Leukocyte antigen CD37 modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication |
Originator Organization |
Active Organization |
Inactive Organization |
License Organization- |
Drug Highest PhasePhase 1 |
First Approval Date- |
Regulation- |
Login to view timeline
Related
1
Clinical Trials associated with QLP-31907NCT05003141
A Phase 1a/1b Study of PSB202 in Patients With Previously Treated-, Relapsed-, Indolent B-Cell Malignancies
100 Clinical Results associated with QLP-31907
Login to view more data
100 Translational Medicine associated with QLP-31907
Login to view more data
100 Patents (Medical) associated with QLP-31907
Login to view more data
100 Deals associated with QLP-31907
Login to view more data
R&D Status
10 top R&D records. to view more data
Login
| Indication | Highest Phase | Country/Location | Organization | Date |
|---|---|---|---|---|
| B-Cell Malignant Neoplasm | Phase 1 | United States | 23 Feb 2022 | |
| B-Cell Malignant Neoplasm | Phase 1 | China | 23 Feb 2022 | |
| B-Cell Malignant Neoplasm | Phase 1 | Australia | 23 Feb 2022 | |
| B-cell lymphoma refractory | Phase 1 | United States | 15 Nov 2021 | |
| B-cell lymphoma refractory | Phase 1 | China | 15 Nov 2021 | |
| B-cell lymphoma refractory | Phase 1 | Australia | 15 Nov 2021 | |
| Chronic Lymphocytic Leukemia | Phase 1 | United States | 15 Nov 2021 | |
| Chronic Lymphocytic Leukemia | Phase 1 | China | 15 Nov 2021 | |
| Chronic Lymphocytic Leukemia | Phase 1 | Australia | 15 Nov 2021 | |
| Follicular Lymphoma | Phase 1 | United States | 15 Nov 2021 |
Login to view more data
Clinical Result
Clinical Result
Indication
Phase
Evaluation
View All Results
Phase 1 | - | bquorxznsp(hbihraphqb) = wdolyswxho wrypxmgzau (nevaaffkin ) | - | 15 Jun 2022 |
Login to view more data
Translational Medicine
Boost your research with our translational medicine data.
login
or
Deal
Boost your decision using our deal data.
login
or
Core Patent
Boost your research with our Core Patent data.
login
or
Clinical Trial
Identify the latest clinical trials across global registries.
login
or
Approval
Accelerate your research with the latest regulatory approval information.
login
or
Biosimilar
Competitive landscape of biosimilars in different countries/locations. Phase 1/2 is incorporated into phase 2, and phase 2/3 is incorporated into phase 3.
login
or
Regulation
Understand key drug designations in just a few clicks with Synapse.
login
or
AI Agents Built for Biopharma Breakthroughs
Accelerate discovery. Empower decisions. Transform outcomes.
Get started for free today!
Accelerate Strategic R&D decision making with Synapse, PatSnap’s AI-powered Connected Innovation Intelligence Platform Built for Life Sciences Professionals.
Start your data trial now!
Synapse data is also accessible to external entities via APIs or data packages. Empower better decisions with the latest in pharmaceutical intelligence.
Bio
Bio Sequences Search & Analysis
Sign up for free
Chemical
Chemical Structures Search & Analysis
Sign up for free